Meprolol (Metoprolol Tartrate)

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, decreasing cyclic AMP production. This leads to a slower heart rate, reduced contractile force, and lower renin release, collectively lowering cardiac output and systemic blood pressure while improving ventricular efficiency.

The dose of Meprolol is individualized. A qualified prescriber determines the appropriate strength, frequency and duration based on the patient’s condition, response, age, renal function and other clinical factors. No generic dosing regimen is provided here.

Safety data for metoprolol tartrate during pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit outweighs possible risks to the fetus or infant. Clinicians should evaluate each case carefully and discuss potential concerns with the patient.

To request Meprolol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Metoprolol tartrate is a cardio‑selective (β1‑selective) blocker, offering a favourable profile for patients with hypertension, angina or heart failure. Compared with non‑selective agents such as propranolol, it has a lower risk of bronchospasm. Relative to atenolol, metoprolol has a shorter half‑life and may require more frequent dosing, but both share similar efficacy in blood‑pressure control.

Store Meprolol at room temperature, typically below 25 °C. Keep the tablets in the original container, protect them from moisture and direct light, and avoid exposure to extreme temperatures or humidity to maintain potency.

Meprolol is administered orally, usually as a tablet. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether to swallow whole or split the dose. Consistency in administration time each day helps maintain stable blood levels.

The most serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with asthma or COPD, and rare cases of hepatic dysfunction. Patients should seek immediate medical attention if they experience fainting, severe dizziness, difficulty breathing, or signs of liver injury.

Meprolol is contraindicated in patients with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block, cardiogenic shock, overt heart failure decompensation, or uncontrolled asthma/COPD. Caution is also advised for individuals with severe peripheral vascular disease or untreated pheochromocytoma.